article thumbnail

Avoid CMC Challenges by Thinking Slow, Not Fast-Discussions at USP’s Workshop

The FDA Law Blog

Brevig, Senior Regulatory Device and Biologics Expert — On October 26, 2022, US Pharmacopeia (USP) Biologics Stakeholder Forum held a workshop on “Collaborating to solve CMC challenges and support efficient development of lentiviral-mediated CART cell therapies.” Opportunity for feedback from FDA if provided pre-BLA. By Holly N.

FDA 59
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Summary from Advanced Manufacturing Technology Workshop Held at 6th Accelerating Biopharmaceutical Development Meeting.” FDA Official Warns Manufacturers of Common Problems Found in Aseptic Operations.” www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/examples-accepted-emerging-technologies 26 Eisner, D.